Skip to main content
Clinical Trials/NL-OMON52353
NL-OMON52353RecruitingNot Applicable

Toddlers receiving synbiotics after antibiotics - TOBBI trial

Wageningen Universiteit0 sites166 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
166

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
0 to 11 (—)

Inclusion Criteria

  • 1. Written informed consent obtained from both caregivers;
  • 2. Caregivers are willing to comply with the requirements of the study;
  • 3. Aged 1 to 4 years old at the time of enrollment;
  • 4. Drinks cow*s milk (non-fat, semi-skimmed or full fat) regularly;
  • 5. Received a prescription for amoxicillin or amoxicillin / clavulanic acid*.
  • * There are no restrictions on use of any (other) antibiotics earlier in life.

Exclusion Criteria

  • 1. Any gastro-intestinal (GI) complaints, known structural GI abnormalities, or
  • previous GI surgery;
  • 2. Clinically significant cardiac, vascular, liver, pulmonary, psychiatric
  • disorders, severe renal insufficiency, human immunodeficiency virus infection,
  • acquired immunodeficiency syndrome, hepatitis B or C or abnormalities of
  • haematology, urinalysis, or blood biochemistry;
  • 3. Known to have an allergy or intolerance to any of the ingredients in the
  • study- or control product, including lactose and cow*s milk protein;
  • 4. Is receiving breastmilk, or has received breastmilk in the last 7 days
  • before start of antibiotic treatment.

Investigators

Similar Trials

Toddlers receiving synbiotics after... | Clinical Trial